{"pmid":32468944,"title":"Time for a culture change: understanding and reducing risk, morbidity and mortality from COVID-19 in those of black and minority ethnicity.","text":["Time for a culture change: understanding and reducing risk, morbidity and mortality from COVID-19 in those of black and minority ethnicity.","Following a number of epidemics in the 21st century, including Ebola and Middle East respiratory syndrome, the SARS-COV-2 virus, causing COVID-19 disease, was declared a pandemic health emergency of international concern in January 2020.","Br J Hosp Med (Lond)","Singh, Iqbal","Chand, Kailash","Singh, Arun","Kandadi, Kondal R","32468944"],"abstract":["Following a number of epidemics in the 21st century, including Ebola and Middle East respiratory syndrome, the SARS-COV-2 virus, causing COVID-19 disease, was declared a pandemic health emergency of international concern in January 2020."],"journal":"Br J Hosp Med (Lond)","authors":["Singh, Iqbal","Chand, Kailash","Singh, Arun","Kandadi, Kondal R"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32468944","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.12968/hmed.2020.0241","topics":["Prevention"],"weight":1,"_version_":1668420887135649792,"score":9.490897,"similar":[{"pmid":32420652,"title":"A nursing informatics response to COVID-19: perspectives from five regions of the world.","text":["A nursing informatics response to COVID-19: perspectives from five regions of the world.","The 21st century has seen several infectious disease outbreaks that have turned into epidemics and pandemics including Severe Acute Respiratory Syndrome (SARS) which began in Asia in 2003 (Poon, Guan, Nicholls, Yuen, & Peiris, 2004), followed by H1N1 that emerged in Mexico and the United States in 2009 (Belongia et al., 2010). Next came the lesser known Middle East Respiratory Syndrome (MERS) originating in Saudi Arabia in 2012 (Assiri et al., 2013), after which the Ebola outbreak in West Africa took place from 2014 to 2016, with a more recent occurrence in the Democratic Republic of Congo from 2018 to 2019 (Malvy, McElroy, de Clerck, Gunther, & van Griensven, 2019). To date, the coronavirus (COVID-19) outbreak that started in Wuhan, in the Hubei province of China, in late December 2019 seems to be eclipsing all of these previous infectious diseases in terms of its global reach and impact (Wang, Horby, Hayden, & Gao, 2020). After being declared by the World Health Organization (WHO) as a public health emergency on 30 January 2020 (World Health Organization, 2020c), it was elevated to a pandemic status on 11 March 2020 (World Health Organization, 2020d). As of 28 April 2020, there are more than 2.9 million cases and 202,597 deaths reported worldwide (World Health Organization, 2020b).","J Adv Nurs","Atique, Suleman","Bautista, John Robert","Block, Lorraine J","Lee, Jay Jung Jae","Lozada-Perezmitre, Erika","Nibber, Raji","O'Connor, Siobhan","Peltonen, Laura-Maria","Ronquillo, Charlene","Tayaben, Jude","Thilo, Friederike J S","Topaz, Maxim","32420652"],"abstract":["The 21st century has seen several infectious disease outbreaks that have turned into epidemics and pandemics including Severe Acute Respiratory Syndrome (SARS) which began in Asia in 2003 (Poon, Guan, Nicholls, Yuen, & Peiris, 2004), followed by H1N1 that emerged in Mexico and the United States in 2009 (Belongia et al., 2010). Next came the lesser known Middle East Respiratory Syndrome (MERS) originating in Saudi Arabia in 2012 (Assiri et al., 2013), after which the Ebola outbreak in West Africa took place from 2014 to 2016, with a more recent occurrence in the Democratic Republic of Congo from 2018 to 2019 (Malvy, McElroy, de Clerck, Gunther, & van Griensven, 2019). To date, the coronavirus (COVID-19) outbreak that started in Wuhan, in the Hubei province of China, in late December 2019 seems to be eclipsing all of these previous infectious diseases in terms of its global reach and impact (Wang, Horby, Hayden, & Gao, 2020). After being declared by the World Health Organization (WHO) as a public health emergency on 30 January 2020 (World Health Organization, 2020c), it was elevated to a pandemic status on 11 March 2020 (World Health Organization, 2020d). As of 28 April 2020, there are more than 2.9 million cases and 202,597 deaths reported worldwide (World Health Organization, 2020b)."],"journal":"J Adv Nurs","authors":["Atique, Suleman","Bautista, John Robert","Block, Lorraine J","Lee, Jay Jung Jae","Lozada-Perezmitre, Erika","Nibber, Raji","O'Connor, Siobhan","Peltonen, Laura-Maria","Ronquillo, Charlene","Tayaben, Jude","Thilo, Friederike J S","Topaz, Maxim"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32420652","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/jan.14417","locations":["Nicholls","Mexico","United States","Saudi Arabia","West Africa","McElroy","Wuhan","Hubei","China","Horby","Hayden"],"countries":["Saudi Arabia","China","Mexico","United States"],"countries_codes":["SAU|Saudi Arabia","CHN|China","MEX|Mexico","USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1667159284487553025,"score":116.36397},{"pmid":32448759,"title":"COVID-19: Unique public health issues facing Black, Asian and minority ethnic communities.","text":["COVID-19: Unique public health issues facing Black, Asian and minority ethnic communities.","The 2019 coronavirus disease is a serious public health emergency, with serious adverse implications for populations, healthcare systems, and economies globally. Recently, concerns have been raised about possible association between ethnicity, incidence and outcomes of COVID-19 arisen from early government data. In this review, we will explore the possible association using both recent COVID-19 studies and studies of previous pandemics. We call for data on ethnicity to be routinely collected by governments, as part of an international collaboration, alongside other patient demographics and further research to robustly determine the magnitude of association. Moreover, governments must learn from previous pandemics and recommended strategies to mitigate risks on minority ethnicities due to socioeconomic disadvantages.","Curr Probl Cardiol","Abuelgasim, Eyad","Saw, Li Jing","Shirke, Manasi","Zeinah, Mohamed","Harky, Amer","32448759"],"abstract":["The 2019 coronavirus disease is a serious public health emergency, with serious adverse implications for populations, healthcare systems, and economies globally. Recently, concerns have been raised about possible association between ethnicity, incidence and outcomes of COVID-19 arisen from early government data. In this review, we will explore the possible association using both recent COVID-19 studies and studies of previous pandemics. We call for data on ethnicity to be routinely collected by governments, as part of an international collaboration, alongside other patient demographics and further research to robustly determine the magnitude of association. Moreover, governments must learn from previous pandemics and recommended strategies to mitigate risks on minority ethnicities due to socioeconomic disadvantages."],"journal":"Curr Probl Cardiol","authors":["Abuelgasim, Eyad","Saw, Li Jing","Shirke, Manasi","Zeinah, Mohamed","Harky, Amer"],"date":"2020-05-26T11:00:00Z","year":2020,"_id":"32448759","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.cpcardiol.2020.100621","topics":["Prevention"],"weight":1,"_version_":1667785213926703104,"score":105.06656},{"pmid":32322993,"pmcid":"PMC7176030","title":"The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century.","text":["The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century.","At the beginning of the 21st century, a new deadly infectious disease known as severe acute respiratory syndrome (SARS) was recognized as a global public health threat. Subsequently, ten years after the initial SARS cases occurred in 2002, new cases of another atypical respiratory disease caused worldwide concern. This disease became known as Middle East respiratory syndrome (MERS) and was even more lethal than SARS. Currently, history has repeated itself with the emergence of a new Chinese epidemic at the end of 2019. For this respiratory disease, called COVID-19, a novel coronavirus (SARS-CoV-2) was identified as the etiologic agent. In sum, SARS, MERS and COVID-19 are caused by recently discovered coronaviruses that cause flu-like illnesses, but with a clinical outcome that tends to be more severe. As a result of the current importance of coronaviruses in global public health, we conducted a review to summarize and update, above all, the epidemiological historical aspects of the three major diseases in humans caused by coronaviral infection.","Arch Virol","da Costa, Vivaldo Gomes","Moreli, Marcos Lazaro","Saivish, Marielena Vogel","32322993"],"abstract":["At the beginning of the 21st century, a new deadly infectious disease known as severe acute respiratory syndrome (SARS) was recognized as a global public health threat. Subsequently, ten years after the initial SARS cases occurred in 2002, new cases of another atypical respiratory disease caused worldwide concern. This disease became known as Middle East respiratory syndrome (MERS) and was even more lethal than SARS. Currently, history has repeated itself with the emergence of a new Chinese epidemic at the end of 2019. For this respiratory disease, called COVID-19, a novel coronavirus (SARS-CoV-2) was identified as the etiologic agent. In sum, SARS, MERS and COVID-19 are caused by recently discovered coronaviruses that cause flu-like illnesses, but with a clinical outcome that tends to be more severe. As a result of the current importance of coronaviruses in global public health, we conducted a review to summarize and update, above all, the epidemiological historical aspects of the three major diseases in humans caused by coronaviral infection."],"journal":"Arch Virol","authors":["da Costa, Vivaldo Gomes","Moreli, Marcos Lazaro","Saivish, Marielena Vogel"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32322993","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1007/s00705-020-04628-0","locations":["Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Transmission","Diagnosis","Prevention"],"weight":1,"_version_":1666138493783375876,"score":95.26479},{"pmid":32347053,"title":"[Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].","text":["[Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].","The ongoing outbreak of the coronavirus disease 2019 (COVID-19) as named by the World Health Organization has millions of confirmed cases around the world and has claimed hundreds of thousands of lives. The virus was named SARS-CoV-2 in February by International Committee on Taxonomy of Viruses. COVID-19 presents as fever, dry cough, dyspnea, headache and pneumonia. In a small subset of severe cases, the disease quickly progresses to respiratory failure and even death. Since the 21st century, there have been three major outbreaks caused by human coronaviruses, including the severe acute respiratory syndrome (SARS) that broke out in 2003, the Middle East respiratory syndrome (MERS) in 2012, and the recent pandemic of COVID-19. Since 2003, significant progress has been made in the study of SARS-CoV and MERS-CoV concerning their natural origins, pathogenesis, antiviral development and vaccine design. Since SARS-CoV-2 and SARS-CoV are closely related, previous findings on SARS-CoV are highly relevant to a better understanding as well as diagnosis, treatment, prevention and control of SARS-CoV-2. In this review, we highlight recent progresses in the field; compare the biological characteristics of SARS-CoV and SARS-CoV-2; summarize the urgently-needed diagnostic, treatment, prevention and control options; and provide future perspectives for the outcome of the outbreak and research questions to be answered, including some of the difficulties in vaccine development. Hopefully, our comments and suggestions would prove useful for the control of the SARS-CoV-2 epidemic in China and the world.","Sheng Wu Gong Cheng Xue Bao","Ye, Zi-Wei","Jin, Dong-Yan","32347053"],"abstract":["The ongoing outbreak of the coronavirus disease 2019 (COVID-19) as named by the World Health Organization has millions of confirmed cases around the world and has claimed hundreds of thousands of lives. The virus was named SARS-CoV-2 in February by International Committee on Taxonomy of Viruses. COVID-19 presents as fever, dry cough, dyspnea, headache and pneumonia. In a small subset of severe cases, the disease quickly progresses to respiratory failure and even death. Since the 21st century, there have been three major outbreaks caused by human coronaviruses, including the severe acute respiratory syndrome (SARS) that broke out in 2003, the Middle East respiratory syndrome (MERS) in 2012, and the recent pandemic of COVID-19. Since 2003, significant progress has been made in the study of SARS-CoV and MERS-CoV concerning their natural origins, pathogenesis, antiviral development and vaccine design. Since SARS-CoV-2 and SARS-CoV are closely related, previous findings on SARS-CoV are highly relevant to a better understanding as well as diagnosis, treatment, prevention and control of SARS-CoV-2. In this review, we highlight recent progresses in the field; compare the biological characteristics of SARS-CoV and SARS-CoV-2; summarize the urgently-needed diagnostic, treatment, prevention and control options; and provide future perspectives for the outcome of the outbreak and research questions to be answered, including some of the difficulties in vaccine development. Hopefully, our comments and suggestions would prove useful for the control of the SARS-CoV-2 epidemic in China and the world."],"journal":"Sheng Wu Gong Cheng Xue Bao","authors":["Ye, Zi-Wei","Jin, Dong-Yan"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32347053","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.13345/j.cjb.200115","keywords":["middle east respiratory syndrome coronavirus","sars-cov-2","antiviral therapy","coronavirus disease 2019 (covid-19)","coronavirus vaccines","severe acute respiratory syndrome coronavirus (sars-cov)","virological diagnosis"],"locations":["SARS-CoV","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis","Prevention"],"weight":1,"_version_":1666138494923177985,"score":90.203926},{"pmid":32314790,"pmcid":"PMC7188130","title":"What's New With the Old Coronaviruses?","text":["What's New With the Old Coronaviruses?","Coronaviruses contribute to the burden of respiratory diseases in children, frequently manifesting in upper respiratory symptoms considered to be part of the \"common cold.\" Recent epidemics of novel coronaviruses recognized in the 21st century have highlighted issues of zoonotic origins of transmissible respiratory viruses and potential transmission, disease, and mortality related to these viruses. In this review, we discuss what is known about the virology, epidemiology, and disease associated with pediatric infection with the common community-acquired human coronaviruses, including species 229E, OC43, NL63, and HKU1, and the coronaviruses responsible for past world-wide epidemics due to severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus.","J Pediatric Infect Dis Soc","Ogimi, Chikara","Kim, Yae Jean","Martin, Emily T","Huh, Hee Jae","Chiu, Cheng-Hsun","Englund, Janet A","32314790"],"abstract":["Coronaviruses contribute to the burden of respiratory diseases in children, frequently manifesting in upper respiratory symptoms considered to be part of the \"common cold.\" Recent epidemics of novel coronaviruses recognized in the 21st century have highlighted issues of zoonotic origins of transmissible respiratory viruses and potential transmission, disease, and mortality related to these viruses. In this review, we discuss what is known about the virology, epidemiology, and disease associated with pediatric infection with the common community-acquired human coronaviruses, including species 229E, OC43, NL63, and HKU1, and the coronaviruses responsible for past world-wide epidemics due to severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus."],"journal":"J Pediatric Infect Dis Soc","authors":["Ogimi, Chikara","Kim, Yae Jean","Martin, Emily T","Huh, Hee Jae","Chiu, Cheng-Hsun","Englund, Janet A"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314790","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1093/jpids/piaa037","keywords":["covid-19","mers","sars","coronavirus","pediatric respiratory viruses"],"topics":["Transmission","Mechanism","Diagnosis"],"weight":1,"_version_":1666138493582049280,"score":89.303215}]}